A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis von Kappos, Ludwig, Radue, Ernst-Wilhelm, O'Connor, Paul, Polman, Chris, Hohlfeld, Reinhard, Calabresi, Peter, Selmaj, Krzysztof, Agoropoulou, Catherine, Leyk, Malgorzata, Zhang-Auberson, Lixin, Burtin, Pascale

Volltext

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial von Hanna, Michael G, Badrising, Umesh A, Benveniste, Olivier, Lloyd, Thomas E, Needham, Merrilee, Chinoy, Hector, Aoki, Masashi, Machado, Pedro M, Liang, Christina, Reardon, Katrina A, de Visser, Marianne, Ascherman, Dana P, Barohn, Richard J, Dimachkie, Mazen M, Miller, James A L, Kissel, John T, Oskarsson, Björn, Joyce, Nanette C, Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L, Karam, Chafic, David, William S, Mirabella, Massimiliano, Nations, Sharon P, Jung, Hans H, Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I, Sivakumar, Kumaraswamy, Goyal, Namita A, Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Katsuno, Masahisa, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D, Williams, Valerie S L, Vissing, John, Auberson, Lixin Zhang, Wu, Min, de Vera, Ana, Papanicolaou, Dimitris A, Amato, Anthony A

Volltext

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study von Selmaj, Krzysztof, Prof, Li, David KB, Prof, Hartung, Hans-Peter, Prof, Hemmer, Bernhard, Prof, Kappos, Ludwig, Prof, Freedman, Mark S, Prof, Stüve, Olaf, MD, Rieckmann, Peter, Prof, Montalban, Xavier, Prof, Ziemssen, Tjalf, MD, Auberson, Lixin Zhang, MD, Pohlmann, Harald, MSc, Mercier, Francois, PhD, Dahlke, Frank, MD, Wallström, Erik, MD

Volltext

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study von Devonshire, Virginia, MD, Havrdova, Eva, MD, Radue, Ernst Wilhelm, Prof, O'Connor, Paul, MD, Zhang-Auberson, Lixin, MD, Agoropoulou, Catherine, PhD, Häring, Dieter Adrian, PhD, Francis, Gordon, MD, Kappos, Ludwig, Prof

Volltext

Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study von Saida, Takahiko, Itoyama, Yasuto, Kikuchi, Seiji, Hao, Qi, Kurosawa, Takayoshi, Ueda, Kengo, Auberson, Lixin Zhang, Tsumiyama, Isao, Nagato, Kazuo, Kira, Jun-Ichi

Volltext

Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial von Hofbauer, Lorenz C, Witvrouw, Richard, Varga, Zsuzsanna, Shiota, Naofumi, Cremer, Malika, Tanko, Laszlo B, Rooks, Daniel, Auberson, Lixin Zhang, Arkuszewski, Michal, Fretault, Nathalie, Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A, Recknor, Chris

Volltext

Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial von Kappos, Ludwig, OʼConnor, Paul, Radue, Ernst-Wilhelm, Polman, Chris, Hohlfeld, Reinhard, Selmaj, Krzysztof, Ritter, Shannon, Schlosshauer, Rolf, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Francis, Gordon

Volltext

Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings von Kappos, Ludwig, Cohen, Jeffrey, Collins, William, de Vera, Ana, Zhang-Auberson, Lixin, Ritter, Shannon, von Rosenstiel, Philipp, Francis, Gordon

Volltext

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT von Amato, Anthony A., Hanna, Michael G., Machado, Pedro M., Badrising, Umesh A., Chinoy, Hector, Benveniste, Olivier, Karanam, Ananda Krishna, Wu, Min, Tankó, László B., Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A., Lloyd, Thomas E., Needham, Merrilee, Liang, Christina, Reardon, Katrina A., de Visser, Marianne, Ascherman, Dana P., Barohn, Richard J., Dimachkie, Mazen M., Miller, James A.L., Kissel, John T., Oskarsson, Björn, Joyce, Nanette C., Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L., Karam, Chafic, David, William S., Mirabella, Massimiliano, Nations, Sharon P., Jung, Hans H., Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I., Sivakumar, Kumaraswamy, Goyal, Namita A., Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D., Williams, Valerie S.L., Vissing, John, Zhang Auberson, Lixin

Volltext

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study von Khatri, Bhupendra, Dr, Barkhof, Frederik, MD, Comi, Giancarlo, MD, Hartung, Hans-Peter, MD, Kappos, Ludwig, MD, Montalban, Xavier, MD, Pelletier, Jean, MD, Stites, Tracy, PhD, Wu, Stacy, MD, Holdbrook, Fred, PhD, Zhang-Auberson, Lixin, MD, Francis, Gordon, MD, Cohen, Jeffrey A, MD

Volltext

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension von Kira, Jun-ichi, Itoyama, Yasuto, Kikuchi, Seiji, Hao, Qi, Kurosawa, Takayoshi, Nagato, Kazuo, Tsumiyama, Isao, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Saida, Takahiko

Volltext

Long-Term Efficacy and Safety of Bimagrumab in Inclusion Body Myositis: 2 Years Results (S38.003) von Amato, Anthony A., Auberson, Lixin Zhang, Hanna, Michael G., Badrising, Umesh A., Needham, Merrilee, Chinoy, Hector, Aoki, Masashi, Koumaras, Barbara, Tanko, Laszlo, Wu, Min, Papanicolaou, Dimitris A., Benveniste, Olivier

Volltext

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis von Amato, Anthony, Hanna, Michael, Machado, Pedro, Badrising, Umesh, Chinoy, Hector, Lloyd, Thomas, Karanam, Ananda Krishna, Benveniste, Olivier, Wu, Min, Tankó, László, Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris, Needham, Merrilee, Liang, Christina, Reardon, Katrina, de Visser, Marianne, Ascherman, Dana, Barohn, Richard, Dimachkie, Mazen, Miller, James A.L., Kissel, John, Oskarsson, Björn, Joyce, Nanette, van den Bergh, Peter, Baets, Jonathan, de Bleecker, Jan, Karam, Chafic, David, William, Mirabella, Massimiliano, Nations, Sharon, Jung, Hans, Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz, Sivakumar, Kumaraswamy, Goyal, Namita, Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla, Williams, Valerie S.L., Vissing, John, Zhang Auberson, Lixin

Volltext

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-Term Extension of RESILIENT von Amato, Anthony A., Hanna, Michael G., Machado, Pedro M., Badrising, Umesh A., Chinoy, Hector, Benveniste, Olivier, Karanam, Ananda Krishna, Wu, Min, Tankó, László B., Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A., Lloyd, Thomas E., Needham, Merrilee, Liang, Christina, Reardon, Katrina A., de Visser, Marianne, Ascherman, Dana P., Barohn, Richard J., Dimachkie, Mazen M., Miller, James A. L., Kissel, John T., Oskarsson, Björn, Joyce, Nanette C., Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L., Karam, Chafic, David, William S., Mirabella, Massimiliano, Nations, Sharon P., Jung, Hans H., Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I., Sivakumar, Kumaraswamy, Goyal, Namita A., Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D., Williams, Valerie S. L., Vissing, John, Auberson, Lixin Zhang

Volltext

First-dose effects of fingolimod: Pooled safety data from three phase 3 studies von DiMarco, John P, O’Connor, Paul, Cohen, Jeffrey A, Reder, Anthony T, Zhang-Auberson, Lixin, Tang, Dejun, Collins, William, Kappos, Ludwig

Volltext

Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD) von Sechaud, Romain, Renard, Didier, Zhang-Auberson, Lixin, Motte, Stephan de la, Drollmann, Anton, Kaiser, Guenther

Volltext

Fingolimod (FTY720) Oral For The Treatment Of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Study Design Of The Phase 3 FORCIDP Trial (P6.103) von Hartung, Hans, Sobue, Gen, Dalakas, Marinos, Latov, Norman, Leger, Jean-Marc, Merkies, Ingemar, Nobile-Orazio, Eduardo, Agoropoulou, Katherine, Häring, Dieter, Zhang-Auberson, Lixin, Von Rosenstiel, Philipp, Hughes, Richard

Volltext

Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial (P07.126) von Kappos, Ludwig, Bar-Or, Amit, Cree, Bruce, Fox, Robert, Giovannoni, Gavin, Gold, Ralf, Vermersch, Patrick, Lam, Elaine, Pohlmann, Harold, Zhang-Auberson, Lixin, Dandekar, Atul, Wallstroem, Erik

Volltext

Relapse and disability outcomes in patients with multiple sclerosis treated with fi ngolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study von Devonshire, Virginia, Havrdova, Eva, Radue, Ernst Wilhelm, O'Connor, Paul, Zhang-Auberson, Lixin, Agoropoulou, Catherine, Häring, Dieter Adrian, Francis, Gordon, Kappos, Ludwig

Volltext

Phase 2 BOLD Extension Study Safety Results for Siponimod (BAF312) in Patients with Relapsing–Remitting Multiple Sclerosis (P01.176) von Hartung, Hans-Peter, Selmaj, Krzysztof, Li, David, Hemmer, Bernhard, Freedman, Mark, Stuve, Olaf, Rieckmann, Peter, Montalban, Xavier, Ziemssen, Tjalf, Zhang-Auberson, Lixin, Hunter, Brian, Rochotte, Erika, Wallstrom, Erik, Kappos, Ludwig

Volltext